OC
TECH icon

Oppenheimer & Co’s Bio-Techne TECH Stock Holding History

Oppenheimer & Co’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$268K Sell
5,132
-219
-4% -$13.1K ﹤0.01% 1442
2025
Q4 		$315K Buy
5,351
+181
+4% +$11K ﹤0.01% 1257
2025
Q3 		$288K Buy
+5,170
New +$277K ﹤0.01% 1407

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Oppenheimer & Co's TECH Position: Q1 2026 in Review

Oppenheimer & Co reduced its Bio-Techne (TECH) stake by 4.1% in Q1 2026, selling an estimated $13.1K and leaving 5,132 shares worth $268K. The position accounts for ﹤0.01% of the portfolio, ranked #1442.

Oppenheimer & Co first reported a position in TECH in Q3 2025 and has held it in 3 quarters since. The position peaked at $315K in Q4 2025. 583 funds tracked by Wall St. Rank hold TECH as of Q1 2026.

  • Oppenheimer & Co held 5,132 shares of Bio-Techne worth $268K as of Q1 2026.
  • Oppenheimer & Co sold 219 Bio-Techne shares in Q1 2026, an estimated $13.1K.
  • Bio-Techne made up ﹤0.01% of Oppenheimer & Co's portfolio in Q1 2026, its #1442 holding.
  • Oppenheimer & Co first reported a position in Bio-Techne in Q3 2025 and has held it in 3 quarters since.
  • Oppenheimer & Co's Bio-Techne position peaked at $315K in Q4 2025.
  • 583 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2026.

Based on Oppenheimer & Co's 13F filing for Q1 2026, filed 24 Apr 2026.